Norway Offshore Oil Workers Reach Wage Deal, Averting Strike 
easyJet Agrees in Principle to £5.23 Billion Castlelake Takeover Offer 
Kioxia Bets on AI Memory Boom With Next-Gen NAND Production in Japan 
Samsung Q2 Profit Seen Soaring as AI Memory Demand Keeps Chip Prices Elevated 
AI Memory Chip Shortage Likely to Persist Despite Korea Investment Boom, Nomura Says 
Anthropic Tightens AI Access Controls After Reports of China-Based Workarounds 
Sodexo Raises 2026 Revenue Outlook After Strong Q3 Sales Beat 
OpenAI Proposes 5% U.S. Government Stake Amid AI Policy Talks 
SoftBank’s LY Corp, Bain Raise Kakaku.com Bid to ¥670 Billion, Intensifying Takeover Battle 
DOJ Seeks Dismissal of Fraud Charges Against Gautam Adani in U.S. Court 
Super Micro Employees Detained in Taiwan AI Server Export Investigation 
Meta CEO Zuckerberg Says AI Agent Development Has Slowed Despite Massive AI Investment 
Suncorp Cuts 2026 Premium Growth Forecast as Australia, New Zealand Markets Weaken 
Lockheed Martin Emerges as Frontrunner to Acquire Ultra Maritime in $3.5 Billion Defense Deal 
Kuaishou Stock Jumps as Kling AI Secures $2 Billion Funding Round 
Citi Raises TSMC Price Target as AI Chip Demand Strengthens Growth Outlook 
South Korean biotech company Celltrion Inc. plans to merge with its two affiliates, Celltrion Healthcare Co. and Celltrion Pharma Inc., to establish a holding company structure by the end of 2021.
Celltrion Group Chairman Seo Jung-jin would establish Celltrion Healthcare Holdings by investing his stakes in Celltrion Healthcare, making the holding company its largest shareholder.
Celltrion Group Chairman Seo Jung-Jin would hold 11.21 percent in Celltrion Healthcare Holdings, which in turn would have a 24.33 percent stake.
The process would be hastened when requirements for relevant laws regarding anti-monopoly and fair trade are met.
Seo noted that the merger would depend upon the wishes of shareholders.
Celltrion is conducting phase one clinical trials on patients of its coronavirus treatment, CT-P59, to evaluate the safety and efficacy of the treatment.
